| Gene symbol | MUSK | Synonyms | CMS9, FADS, FADS1 | Type of gene | protein-coding | |
| Chromosome | 9 | Map location | 9q31.3 | dbXrefs | Entrez:4593 MIM:601296 HGNC:HGNC:7525 Ensembl:ENSG00000030304 AllianceGenome:HGNC:7525 | |
| Gene perturbation-related omics dataset | PerturbAtlas | |||||
| Description | muscle associated receptor tyrosine kinase | |||||
| GTO ID | GTC3107 |
| Trial ID | NCT05451212 |
| Disease | Myasthenia Gravis |
| Altered gene | MuSK |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MuSK-CAART |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Open-label Study to Evaluate the Safety of Various Dosing Regimens of MuSK-CAART for MuSK Myasthenia Gravis |
| Year | 2022 |
| Country | United States |
| Company sponsor | Cabaletta Bio |
| Other ID(s) | CAB-MuSK-101 |
| Cohort 1 | |||||||||||
|
|||||||||||